Apollomics Statistics

Total Valuation

Apollomics has a market cap or net worth of $42.33 million. The enterprise value is $9.01 million.

Market Cap	42.33M
Enterprise Value	9.01M

Important Dates

The last earnings date was Thursday, March 28, 2024, before market open.

Earnings Date	Mar 28, 2024
Ex-Dividend Date	n/a

Share Statistics

Apollomics has 89.50 million shares outstanding. The number of shares has increased by 566.40% in one year.

Shares Outstanding	89.50M
Shares Change (YoY)	+566.40%
Shares Change (QoQ)	+3.09%
Owned by Insiders (%)	32.02%
Owned by Institutions (%)	10.46%
Float	52.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.02
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.11.

Current Ratio	2.95
Quick Ratio	n/a
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,149.61

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-261.80%
Return on Capital (ROIC)	-217.06%
Revenue Per Employee	n/a
Profits Per Employee	-$3.84M
Employee Count	45
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Apollomics has paid $10,000 in taxes.

Income Tax	10,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -91.06% in the last 52 weeks. The beta is 1.29, so Apollomics's price volatility has been higher than the market average.

Beta (1Y)	1.29
52-Week Price Change	-91.06%
50-Day Moving Average	0.64
200-Day Moving Average	2.14
Relative Strength Index (RSI)	29.94
Average Volume (30 Days)	196,333

Short Selling Information

The latest short interest is 155,139, so 0.17% of the outstanding shares have been sold short.

Short Interest	155,139
Short Previous Month	45,775
Short % of Shares Out	0.17%
Short % of Float	0.30%
Short Ratio (days to cover)	0.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-99.62M
Pretax Income	-172.59M
Net Income	-172.60M
EBITDA	-171.77M
EBIT	-172.44M
Earnings Per Share (EPS)	-$2.32

Full Income Statement

Balance Sheet

The company has $37.82 million in cash and $4.66 million in debt, giving a net cash position of $33.16 million or $0.37 per share.

Cash & Cash Equivalents	37.82M
Total Debt	4.66M
Net Cash	33.16M
Net Cash Per Share	$0.37
Equity / Book Value	41.23M
Book Value Per Share	0.46
Working Capital	26.37M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.20 million and capital expenditures $52,000, giving a free cash flow of -$43.15 million.

Operating Cash Flow	-43.20M
Capital Expenditures	52,000
Free Cash Flow	-43.15M
FCF Per Share	-$0.48

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Apollomics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-566.40%
Shareholder Yield	-566.40%
Earnings Yield	-409.38%
FCF Yield	-102.34%

Analyst Forecast

The average price target for Apollomics is $5.75, which is 1,115.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.75
Price Target Difference	1,115.65%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1